Similar articles

• Ten-year outcomes from a randomised comparison of zotarolimus-eluting and sirolimus-eluting stents: the SORT OUT III study.

  Pareek M, Madsen M, Warnakula Olesen KK, Okkels Jensen L, Høj Christiansen E, Dalby Kristensen S, Flensted Lassen J, Thuesen L, Bøtker HE, Maeng M. Pareek M, et al. EuroIntervention. 2019 Dec 6;15(11):e1022-e1024. doi: 10.4244/EIJ-D-19-00503. EuroIntervention. 2019. PMID: 31422923 No abstract available.
• Efficacy and safety of zotarolimus-eluting stents compared with sirolimus-eluting stents in patients undergoing percutaneous coronary interventions--a meta-analysis of randomized controlled trials.

  Fan J, Du H, Yin Y, Ling Z, Wu J, Xiao P, Zrenner B. Fan J, et al. Int J Cardiol. 2013 Sep 1;167(5):2126-33. doi: 10.1016/j.ijcard.2012.05.105. Epub 2012 Jun 15. Int J Cardiol. 2013. PMID: 22703941
• 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.

  Caixeta A, Leon MB, Lansky AJ, Nikolsky E, Aoki J, Moses JW, Schofer J, Morice MC, Schampaert E, Kirtane AJ, Popma JJ, Parise H, Fahy M, Mehran R. Caixeta A, et al. J Am Coll Cardiol. 2009 Sep 1;54(10):894-902. doi: 10.1016/j.jacc.2009.04.077. J Am Coll Cardiol. 2009. PMID: 19712798
• Current status of the Xience V® everolimus-eluting coronary stent system.

  Claessen BE, Caixeta A, Henriques JP, Piek JJ. Claessen BE, et al. Expert Rev Cardiovasc Ther. 2010 Oct;8(10):1363-74. doi: 10.1586/erc.10.127. Expert Rev Cardiovasc Ther. 2010. PMID: 20936921 Review.
• Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trials.

  De Luca G, Dirksen MT, Spaulding C, Kelbaek H, Schalij M, Thuesen L, van der Hoeven B, Vink MA, Kaiser C, Musto C, Chechi T, Spaziani G, Díaz de la Llera LS, Pasceri V, Di Lorenzo E, Violini R, Cortese G, Suryapranata H, Stone GW; Drug-Eluting Stent in Primary Angioplasty (DESERT) Cooperation. De Luca G, et al. Arch Intern Med. 2012 Apr 23;172(8):611-21; discussion 621-2. doi: 10.1001/archinternmed.2012.758. Arch Intern Med. 2012. PMID: 22529227 Review.